FDA begins push to study psychedelics for mental health disorders
UPI
—
https://cdnph.upi.com/ph/st/th/9451777053217/2026/upi/d78637ffd44b608d67f39082e18a893f/v1.5/FDA-begins-push-to-study-psychedelics-for-mental-health-disorders.jpg" /> The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.
- U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV News —
- US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive South China Morning Post —
- FDA grants quick review for 3 psychedelic drug trials NBC News —
- FDA fast-tracks psychedelic drug research following Trump executive order CNBC —
- FDA plans fast review of 3 psychedelic drugs following Trump directive Boston Globe —